Aneurysm
LeMaitre Vascular Receives IDE Approval to Begin the 'Unite' UniFit Abdominal Stent Graft Pivotal Study
Published in Gastroenterology Week, May 21st, 2007
LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced that it has received approval from the United States Food and Drug Administration (FDA) for an investigational device exemption (IDE) supplement to conduct its UNITE Aorto-Uni-Iliac Stent Graft Clinical Trial. This pivotal study will evaluate the safety and effectiveness of the company's UniFit Abdominal Stent Graft in the treatment of aorto, aorto-iliac, and/or iliac aneurysms. LeMaitre Vascular had previously received conditional FDA approval for its IDE supplement.
"Although we had initiated two study sites based upon conditional approval, many other hospitals, though eager to participate, have been waiting for the FDA...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
More Articles from Gastroenterology Week
- Bipolar Disorders
Survey estimates more than 4 percent of US adults have some form of bipolar disorder - Colon Cancer
Comparison of patients' access to new and better cancer drugs reveals inequalities between countries - Pancreatic Cancer
Swedish snus much safer than smoking but linked to pancreatic cancer - Skin Cancer
Skin Cancer Survivors Join Dermatologists to Educate Teens About Risks of Indoor Tanning - Type 1 Diabetes
Surprising findings points to shift in quest for novel diabetes treatments - Bariatrics
USGI Medical Announces the Use of EndoSurgical Operating System to Reduce the Pouch and Stoma of Post Gastric Bypass Patients - More from this issue of Gastroenterology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
